NO981077L - Isoxazolidinderivater - Google Patents

Isoxazolidinderivater

Info

Publication number
NO981077L
NO981077L NO981077A NO981077A NO981077L NO 981077 L NO981077 L NO 981077L NO 981077 A NO981077 A NO 981077A NO 981077 A NO981077 A NO 981077A NO 981077 L NO981077 L NO 981077L
Authority
NO
Norway
Prior art keywords
6alkyl
zero
pct
independently
optionally substituted
Prior art date
Application number
NO981077A
Other languages
English (en)
Other versions
NO310077B1 (no
NO981077D0 (no
Inventor
Josu Ignacio Andrus-Gil
Pedro Martynez-Jimunez
Francisco Javi Fernsndez-Gadea
Victor Karel Sipido
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO981077D0 publication Critical patent/NO981077D0/no
Publication of NO981077L publication Critical patent/NO981077L/no
Publication of NO310077B1 publication Critical patent/NO310077B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO981077A 1996-04-12 1998-03-11 Isoksazolidinderivater NO310077B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200991 1996-04-12
PCT/EP1997/001830 WO1997039001A1 (en) 1996-04-12 1997-04-09 Isoxazolidine derivatives

Publications (3)

Publication Number Publication Date
NO981077D0 NO981077D0 (no) 1998-03-11
NO981077L true NO981077L (no) 1998-10-12
NO310077B1 NO310077B1 (no) 2001-05-14

Family

ID=8223869

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981077A NO310077B1 (no) 1996-04-12 1998-03-11 Isoksazolidinderivater

Country Status (20)

Country Link
US (1) US6156747A (no)
EP (1) EP0892804B1 (no)
JP (1) JP4299884B2 (no)
KR (1) KR100598724B1 (no)
CN (1) CN1082963C (no)
AT (1) ATE222911T1 (no)
AU (1) AU716470B2 (no)
DE (1) DE69714980T2 (no)
DK (1) DK0892804T3 (no)
ES (1) ES2182064T3 (no)
HU (1) HU221608B (no)
IL (1) IL123656A (no)
MY (1) MY117456A (no)
NO (1) NO310077B1 (no)
NZ (1) NZ329954A (no)
PL (1) PL186541B1 (no)
PT (1) PT892804E (no)
TW (1) TW514637B (no)
WO (1) WO1997039001A1 (no)
ZA (1) ZA973122B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO588297A0 (en) * 1997-03-26 1997-04-24 Luminis Pty Limited Mediation in melatonin production
US20050148018A1 (en) 1999-10-07 2005-07-07 David Weiner Methods of identifying inverse agonists of the serotonin 2A receptor
UA77650C2 (en) 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
MXPA03007432A (es) * 2001-02-21 2003-11-18 Janssen Pharmaceutica Nv Derivados de isoxazolinas y su uso como antidepresivos.
CN101107254B (zh) * 2005-01-27 2010-12-08 詹森药业有限公司 在中枢神经系统病症的治疗中作为5ht2抑制剂的杂环四环四氢呋喃衍生物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7414038A (nl) * 1974-10-28 1976-05-03 Akzo Nv Nieuwe tetracyclische pyrrolidino derivaten.
RU2048469C1 (ru) * 1989-10-05 1995-11-20 Санкио Компани Лимитед Способ получения азетидинового производного или его фармацевтически приемлемой соли
US5552399A (en) * 1994-11-02 1996-09-03 Janssen Pharmaceutica N.V. Substituted tetracyclic azepine derivatives
AU699545B2 (en) * 1994-11-02 1998-12-03 Janssen Pharmaceutica N.V. Substituted tetracyclic oxazepine and thiazepine derivatives with 5-HT2 receptor affinity

Also Published As

Publication number Publication date
CN1205010A (zh) 1999-01-13
IL123656A0 (en) 1998-10-30
ZA973122B (en) 1998-10-12
MY117456A (en) 2004-06-30
ES2182064T3 (es) 2003-03-01
NZ329954A (en) 1999-07-29
PL326871A1 (en) 1998-10-26
KR100598724B1 (ko) 2006-10-25
HUP9901875A2 (hu) 1999-09-28
TW514637B (en) 2002-12-21
PT892804E (pt) 2003-01-31
EP0892804B1 (en) 2002-08-28
IL123656A (en) 2001-09-13
JP4299884B2 (ja) 2009-07-22
AU716470B2 (en) 2000-02-24
AU2385297A (en) 1997-11-07
HUP9901875A3 (en) 2000-06-28
US6156747A (en) 2000-12-05
KR19990067515A (ko) 1999-08-25
DK0892804T3 (da) 2002-12-02
HU221608B (hu) 2002-11-28
NO310077B1 (no) 2001-05-14
DE69714980T2 (de) 2003-04-10
JP2000508328A (ja) 2000-07-04
DE69714980D1 (de) 2002-10-02
EP0892804A1 (en) 1999-01-27
WO1997039001A1 (en) 1997-10-23
ATE222911T1 (de) 2002-09-15
PL186541B1 (pl) 2004-01-30
NO981077D0 (no) 1998-03-11
CN1082963C (zh) 2002-04-17

Similar Documents

Publication Publication Date Title
DE69720709D1 (de) Substituierte tetracyclische tetrahydrofuranderivate
CA2305612A1 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
NO981077D0 (no) Isoxazolidinderivater
IL127177A (en) ANTIPYSYCHOTIC 5-(1, 3, 4, 4a, 5, 9b-HEXAHYDRO-PYRIDO (3, 4-b) INDOL-2-YLALKYL) PYRIMIDIN-4-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL104498A0 (en) Pyrroloimidazolyl or imidazopyridinyl substituted 1h-benzimidazole derivatives,their preparation and pharmaceutical compositions containing them
CA2232195A1 (en) Isoxazolidine derivatives
ZA959216B (en) SUbstituted tetracyclic oxazepine and thiazepine derivatives
MX9703250A (es) Derivados tetraciclicos de oxazepina y tiazepina sustituidos con afinidad al receptor de 5-ht2.

Legal Events

Date Code Title Description
MK1K Patent expired